Don't want to dampen expectations, but I have a bad feeling about this trading halt
Trading halts are not usually used when results are overwhelmingly positive
Some examples where trading halts were not used for positive clinical results/approvals include:
Clarity Pharmaceuticals and the SeCURE PH2 trial update for Cohort 2 (29/11/2023 SECuRE theranostic prostate cancer trial progresses)
Telix Pharmaceuticals Receives TGA approval (02/11/2021 Australian TGA Approves Illuccix for Prostate Cancer Imaging )
Cyclopharm (02/10/2023 Cyclopharm Receives USFDA Approval for Technegas)
On the other hand for trading halts when negative news were received
Rhythm Biosciences - TGA resubmission (01/03/2023 Trading Halt , 06/03/2023 Update to TGA Submission )
Botanix - (26/09/2023 FDA Letter Requires Patient Instruction Update , 25/09/2023 Trading Halt $)
There's probably more, but these are the ones I'm tracking since I have held or held previously
Cross fingers and hope for the best on the Phase II trial results. Try not to have any expectations.
[held]